Tag: #nasdaq

Lifeward Restores Nasdaq Compliance After Audit Committee Shortfall

Israeli exoskeleton maker Lifeward says Nasdaq has closed a governance deficiency after new audit committee appointments, as bid-price pressure persists.

#nasdaq, #lifeward, #medicaldevices, #corporategovernance, #delisting

MediaCo posts 40% revenue jump in 2025 as losses widen after EstrellaTV deal

Owner of Hot 97, WBLS and EstrellaTV reports $133.3M in 2025 revenue but a $66.2M loss, citing impairments, warrant swings and debt costs.

#broadcasting, #streaming, #earnings, #nasdaq, #multiculturalmedia

GoHealth Reports 55% Revenue Drop and $498 Million Loss as Medicare Broker Pulls Back

GoHealth posted a steep 2025 revenue decline and a $498M loss after cutting Medicare Advantage enrollments, taking big impairments, and facing Nasdaq warnings.

#medicareadvantage, #insurance, #nasdaq, #earnings, #healthcare

Workhorse’s first post‑Motiv earnings show revenue surge, deeper losses and a reshaped balance sheet

After merging with Motiv, Workhorse reported triple‑digit revenue growth and more deliveries in 2025, but widened losses and negative margins.

#workhorse, #electricvehicles, #earnings, #mergers, #nasdaq

Oramed Sells Oral-Insulin Unit to Lifeward, Takes Major Stake in Exoskeleton Maker

Oramed sells its oral drug unit to Lifeward, receiving shares, warrants, royalties and convertible notes—positioning it as a near-control shareholder.

#biotech, #medtech, #nasdaq, #exoskeleton, #convertiblenotes

Strategy keeps STRC preferred dividend at 11.5%, reinforcing high-yield funding for its bitcoin bet

Strategy maintained an 11.5% dividend on its STRC preferred shares, with payouts expected to be treated as return of capital, as it continues funding bitcoin buys.

#bitcoin, #preferredstock, #dividends, #nasdaq, #microstrategy

A Tale of Two Listings: FreeCast’s Tiny Direct Debut and PayPay’s $1.1 Billion Nasdaq Test

FreeCast begins trading via direct listing while Japan’s PayPay prepares a major U.S. IPO—together showing the uneven reopening of 2026’s listings market.

#ipo, #nasdaq, #fintech, #streaming, #softbank

AstraZeneca quits Nasdaq, shifts U.S. trading to NYSE in direct listing of ordinary shares

AstraZeneca will delist its Nasdaq ADRs and begin trading its ordinary shares on the NYSE, simplifying global trading and exiting the Nasdaq-100.

#astrazeneca, #nyse, #nasdaq, #adrs, #ukmarkets

Micro-Cap Cold-Chain Firm VerifyMe Becomes Unexpected Crypto Bet After Tokenization Merger Plan

VerifyMe shares soared after a proposed reverse merger would hand control to Cayman-based Open World, aiming to take real-world-asset tokenization public.

#crypto, #tokenization, #nasdaq, #reversemerger, #microcap

Nasdaq Seeks SEC Approval to Trade Tokenized Securities

Nasdaq moves to integrate blockchain with plans to trade tokenized securities on major U.S. exchange, pending SEC approval.

#nasdaq, #sec, #tokenizedsecurities, #blockchain, #financialmarkets

Nasdaq Proposes Stricter Listing Standards to Protect Investors

Nasdaq aims to enhance investor protection with stricter listing standards, pending SEC approval, to curb market manipulation.

#nasdaq, #investorprotection, #sec, #chinesefirms, #usmarkets

Gemini Announces IPO Amid Financial Challenges and Regulatory Shift

Gemini files for IPO, aiming to list on Nasdaq amidst financial losses and regulatory changes in the crypto market.

#gemini, #cryptocurrency, #ipo, #nasdaq, #market

Figure Technology Solutions Files for IPO, Marking a Milestone in Blockchain Finance

Blockchain lender Figure Technology Solutions files for IPO on Nasdaq, reporting a 22.4% revenue rise and strategic market moves.

#ipo, #blockchain, #nasdaq, #fintech, #figuretechnology

Chime Financial's Strong Nasdaq Debut Signals IPO Market Resurgence

Chime Financial's IPO debuts strongly on Nasdaq, reflecting renewed investor interest in fintech and fueling U.S. IPO market revival.

#fintech, #ipo, #stockmarket, #nasdaq

Chime Financial Debuts on Nasdaq, Signals Reviving IPO Market

Chime's IPO opens strong, signals revival in fintech and broader IPO market. Shares rise 59% from IPO price.

#chime, #ipo, #fintech, #nasdaq